Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Osteodex (alendronate/dextran/guanidine) / DexTech
2022-001635-91: A Phase I/IIa Study of ODX (OsteoDex) in Multiple Myeloma	Ongoing	1/2	20	Europe	Osteodex, ODX, Solution for infusion	DexTech Medical AB, DexTech Medical AB	Multiple myeloma Multiple myeloma, Multiple myeloma Multiple myeloma, Diseases [C] - Blood and lymphatic diseases [C15]
NCT06616389: Study of ODX (OsteoDex) in Multiple Myeloma	Recruiting	1/2	12	Europe	ODX (Osteodex)	DexTech Medical AB	Multiple Myeloma	06/25	06/25